ºüÀêÊÓƵ

Signaling molecules called EETs could improve insulin resistance, a primary risk factor for Type 2 diabetes and cardiovascular disease, Vanderbilt researchers have discovered.

Minimizing variation in how rejection is diagnosed and creating standardized surveillance protocols may help inform best practices in pediatric heart transplants.

A combination of two broadly acting monoclonal antibodies isolated by researchers at Vanderbilt University Medical Center protected non-human primates from ebolavirus disease, which causes severe and often-fatal hemorrhagic fever in humans.

Vanderbilt researchers are exploring the outcomes and experiences of Black and White athletes following a sports-related concussion.

Patients with schizophrenia have functional changes in the white matter of the brain, Vanderbilt researchers have discovered, which may contribute to impaired working memory and processing speed.

Hospitalized patients with COVID-19 who received the rheumatoid arthritis drug baricitinib, in combination with the standard of care including corticosteroids, died less often than those receiving only the standard of care, according to a study released this week.

The tumor suppressor protein p53 is mutated in more than half of all human cancers. Several drugs that potentially can restore mutant p53 to its normal cancer-killing function are in clinical investigation.

Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, reminds us the reasons to get vaccinated. Read More

Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, explains how signals on deaths after COVID-19 is collected and interpreted. Read More

Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, shares what we know about COVID-19 booster shots. Read More

A multi-institutional team led by researchers at Vanderbilt University Medical Center has isolated monoclonal antibodies that prevent infection by alphaviruses, including the often-lethal Eastern equine encephalitis virus.

A high-fat diet disrupts the biology of the gut’s inner lining and its microbial communities — and promotes the production of a metabolite that may contribute to heart disease, according to a study published Aug. 13 in the journal Science.

Vanderbilt neurologists found altered excitability in deep brain structures that they note may drive respiratory dysfunction and sudden death in a rare form of epilepsy.

Helicobacter pylori, a stomach-dwelling bacterium, is a strong risk factor for gastric cancer, peptic ulcers and other debilitating gastrointestinal disorders.

2.2 million patients admitted to U.S. hospitals in 1994 were either admitted due to a serious adverse drug reaction or had a serious ADR while in the hospital. With BioVU, researchers are conducting a retrospective scan for information that confer risk of an ADR involves a search for exposures to the drug of interest and natural language processing of clinical notes to sort out normal and abnormal drug responses.

A research team from Vanderbilt University Medical Center reports in Neurology that greater stiffening of the aorta, the main artery in the human body, is associated in older adults with increased Alzheimer’s disease (AD) pathology as reflected in a ra...

Researchers at Vanderbilt University Medical Center have discovered a new genetic disease that causes a severe form of neurogenic orthostatic hypotension, a rapid drop in blood pressure upon standing that can cause fainting.

Patients who, perhaps unbeknownst to their health care providers, are in need of genetic testing for rare undiagnosed diseases can be identified en masse based on routine information in electronic health records (EHRs), a research team reported June 3.

Aviv Regev, PhD, an internationally known computational biologist and executive vice president of Genentech Research and Early Development (gRED), is the recipient of the 2021 Vanderbilt Prize in Biomedical Science, officials at Vanderbilt University Medical Center announced this week.

Vanderbilt-Ingram Cancer Center researchers will present data on clinical trials involving targeted therapies, immunotherapies and drug combination synergies at the 2021 American Society of Clinical Oncology Annual Meeting, June 4-8. The meeting is a virtual event this year.